Skip to content

Clinical trials

Observational Dyslipidemias trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Phase: Observational Clear all

216 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20033
20042
20054
20064
20079
200810
20098
201010
20119
201213
20134
201413
20158
201611
20178
20188
201910
20208
202113
202212
202311
202410
202511
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed120
Unknown status41
Recruiting20
Active, not recruiting15
Not yet recruiting10
Withdrawn4
Terminated3
Suspended2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca20
Daewoong Pharmaceutical Co. LTD.7
John Sievenpiper7
National Heart, Lung, and Blood Institute (NHLBI)5
Assiut University4
University of Toronto4
Hanmi Pharmaceutical Company Limited3
Organon and Co3
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3
Abbott2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias216
Hypertension62
Diabetes Mellitus45
Obesity45
Cardiovascular Diseases41
Diabetes Mellitus, Type 230
Metabolic Syndrome28
Hypercholesterolemia21
Insulin Resistance17
Atherosclerosis15

Trials

Showing 51 to 75 of 216. Each trial links to its page on Pharma Observatory.

116 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.